23 May 2013
Keywords: albany, drug, discovery, deal, alcon, firms, molecular
Article | 17 January 2005
US firms Albany Molecular Research and Alcon Research have entered into a two-year research collaboration to discover and develop ophthalmic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 January 2005
22 May 2013
© 2013 thepharmaletter.com